Risk group stratification in patients undergoing permanent 125I prostate brachytherapy as monotherapy

This publication has 30 references indexed in Scilit:

• 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Modern prostate brachytherapy.
  CA: A Cancer Journal for Clinicians, 2000
• RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER PROVIDES DURABLE CANCER CONTROL WITH EXCELLENT QUALITY OF LIFE: A STRUCTURED DEBATE
  Journal of Urology, 2000
• Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Palladium-103 brachytherapy for prostate carcinoma
  Published by Elsevier ,2000
• A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution
  Cancer, 2000
• Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
  JAMA, 1998
• Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.
  Journal of Clinical Oncology, 1996